Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy

Arch Neurol. 2006 Jun;63(6):851-6. doi: 10.1001/archneur.63.6.851.

Abstract

Background: Myasthenia gravis (MG) and neuromyelitis optica (NMO, also known as Devic disease) are rare autoimmune disorders, with upper-limit prevalence estimates in the general population of 15 per 100,000 and 5 per 100,000, respectively. To our knowledge, an association between these diseases has not been previously reported.

Objectives: To describe 4 patients with MG who developed NMO after thymectomy and to analyze possible causes of apparent increased prevalence of NMO among patients with MG.

Design: Case series.

Patients: Four patients with MG who underwent thymectomy.

Interventions: None.

Results: The prevalence of MG within the published cohort of patients with NMO is more than 150 times higher than that in the general population.

Conclusion: Dysregulation of B-cell autoimmunity in myasthenia, possibly exacerbated by loss of control over autoreactive cells as a result of thymectomy, may predispose patients to the development of NMO.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Adult
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Myasthenia Gravis / complications
  • Myasthenia Gravis / pathology
  • Myasthenia Gravis / surgery*
  • Neuromyelitis Optica / complications
  • Neuromyelitis Optica / pathology
  • Neuromyelitis Optica / surgery*
  • Thymectomy / methods*
  • Treatment Outcome